Ectopic pregnancies: Catch them early, treat them wisely!

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Ectopic Pregnancy Management

Background:

• Ectopic pregnancy (EP) is a common obstetric complication.
• Management protocols for hemodynamically stable EP patients vary, with limited definitive recommendations, especially in resource-limited settings.

Purpose of the Study:

• To determine the outcomes of ectopic pregnancy in hemodynamically stable patients.
• To evaluate factors predicting the success of specific management protocols for ectopic pregnancy.

Main Methods:

• Patients were stratified by serum hCG levels: expectant management (<1500 mIU/ml), methotrexate (MTX) (1500-5000 mIU/ml), and surgical management (>5000 mIU/ml).
• Outcomes and success predictors were analyzed for each management group.

Main Results:

• Expectant management achieved a 92.7% success rate; MTX treatment had an 80% success rate.
• Initial hCG levels were the sole significant predictor of success in the expectant management group (P < 0.05).
• Ultrasound (USG) findings, including mass size and pelvic fluid, did not significantly correlate with hCG levels or predict non-surgical management success.

Conclusions:

• Initial hCG levels are paramount for predicting successful non-surgical ectopic pregnancy treatment.
• Expectant management is highly successful for hCG <1500 mIU/ml (especially <1000 mIU/ml).
• MTX is effective for hCG <5000 mIU/ml, often with a single dose for levels <3000 mIU/ml; pelvic fluid on USG supports non-surgical approaches.